Biotech firm stocks rise on FDA vaccine head's exit
Source: SeekingAlpha
2026-03-09 09:40:31 ET
More on uniQure, Regenxbio, etc.
- Assessing Where Regenxbio Stands After FY25 Results
- REGENXBIO Inc. (RGNX) Q4 2025 Earnings Call Transcript
- uniQure: Worst Case Scenario Becomes Reality
- uniQure surges following departure of key FDA official
- Solid Biosciences announces $240 million private placement
Read the full article on Seeking Alpha
For further details see:
Biotech firm stocks rise on FDA vaccine head’s exit
uniQure N.V.
NASDAQ: QURE
QURE Trading
7.81% G/L:
$18.78 Last:
2,116,451 Volume:
$17.96 Open:
QURE Latest News
QURE Stock Data
$1,555,111,367
59,307,892
N/A
61
N/A
Biotechnology & Life Sciences
Healthcare
NL
Amsterdam
